Author:
Fujimoto Toshihiro,Omote Kazuhiko,Mai Masayoshi,Natsuume-Sakai Shunnosuke
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Mai M, Takahashi Y, Ueno M. Multimodal therapy for gastric cancer based on biological variability (in Japanese with English abstract). Oncologia 1987; 20: 66–76.
2. Fujimoto T, Mai M, Omote K, Ueda H, Takahashi Y, Ogino T. Intraoperative immunotherapy against peritoneal dissemination of gastric cancer with high-dose administration of intraperitoneal Mitomycin-C and OK 432 (in Japanese with English abstract). Biotherapy 1990; 4: 95–100.
3. Taniguchi R, Matsui H, Fujita R, Takaoka C, Kashima N, Yoshimoto R, Hamuro J. Structure and expression of cloned cDNA for human interleukin-2. Nature 1983; 302: 305–310.
4. Thompson JA, Lee DJ, Lindgren CG, Benz LA, Collins C, Levitt D, Fefer A. Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation. J Clin Oncol 1988; 6: 669–678.
5. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE. A progress report on the treatment of 157 patients with advanced cancer using lymphokine activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889–897.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献